Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
470-11-158 ISMRM Abstract

Non-Invasive Prediction of IDH Mutation in Gliomas Using MEGA-PRESS and an Attention Deep Shallow Network (ADSN)

Accepted
Arda Canbaş 1, Abdullah Bas1, Ayca Ersen Danyeli2,3, Cengiz M Yakıcıer4, Necmettin M Pamir3,5, Koray Özduman3,5, Alp Dinçer3,6, Esin Ozturk Isik1,3
1Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey
2Departmant Of Pathology, Acibadem University, Istanbul, Turkey
3Center for Neuroradiological Applications and Research, Acibadem University, Istanbul, Turkey
4YoctoSensum Biotechnology, Turkey
5Department of Neurosurgery, Acibadem University, Istanbul, Turkey
6Department of Radiology, Acibadem University, Istanbul, Turkey
Presenting Author: Arda Canbaş

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Mesfin, F. B., Karsonovich, T., & Al-Dhahir, M. A. (2024, August 12). Gliomas. StatPearls - NCBI Bookshelf. PMID: 28722904 https://www.ncbi.nlm.nih.gov/books/NBK441874/ [pmid]
2. Louis, D. N., Perry, A., Wesseling, P. (2021). The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncology, 23(8), 1231–1251. https://doi.org/10.1093/neuonc/noab106 [doi]
3. Branzoli, F., & Marjańska, M. (2020). Magnetic resonance spectroscopy of isocitrate dehydrogenase mutated gliomas: current knowledge on the neurochemical profile. Current Opinion in Neurology, 33(4), 413–421. https://doi.org/10.1097/wco.0000000000000833 [doi]
4. De Los Santos-Jiménez, J., Campos-Sandoval, J. A., Alonso, F. J. (2024). GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells. Antioxidants, 13(6), 745. https://doi.org/10.3390/antiox13060745 [doi]
5. Pascuzzo, R., Rudà, R., Barker, P. (2025). Glutamate to GABA ratio is elevated in patients with IDH-mutant lower grade gliomas and seizures. Neuro-Oncology Advances. https://doi.org/10.1093/noajnl/vdaf155 [doi]
6. Nguyen, T. B., Melkus, G., Taccone, M. (2020). Preoperative determination of isocitrate dehydrogenase mutation in Gliomas using Spectral Editing MRS: A prospective study. Journal of Magnetic Resonance Imaging, 53(2), 416–426. https://doi.org/10.1002/jmri.27366 [doi]
7. Gong, T., Zhang, X., Wei, X., (2020). GSH and GABA decreases in IDH1-mutated low-grade gliomas detected by HERMES spectral editing at 3 T in vivo. Neurochemistry International, 141, 104889. https://doi.org/10.1016/j.neuint.2020.104889 [doi]
8. Hui, S. C. N., Saleh, M. G., Zöllner, H. J.,(2022). MRSCloud: A cloud‐basedMRStool for basis set simulation. Magnetic Resonance in Medicine, 88(5), 1994–2004. https://doi.org/10.1002/mrm.29370 [doi]
9. Provencher, S. W. (2001). Automatic quantitation of localized in vivo1H spectra withLCModel. NMR in Biomedicine,14(4), 260–264. https://doi.org/10.1002/nbm.698 [doi]
10. Sacli-Bilmez, B., Bas, A., Danyeli, A. E., Yakicier, M. C., Pamir, M. N., Özduman, K., Dinçer, A., & Ozturk-Isik, E. (2025). Detecting IDH and TERTp mutations in diffuse gliomas using 1H-MRS with attention deep-shallow networks. Computers in Biology and Medicine, 186, 109736. https://doi.org/10.1016/j.compbiomed.2025.109736 [doi]
11. Akiba, Takuya & Sano, Shotaro & Yanase, Toshihiko & Ohta (2019). Optuna: A Next-generation Hyperparameter Optimization Framework. 2623-2631. doi:10.1145/3292500.3330701 [doi]
12. Nagashima, H., Tanaka, K., Sasayama, T., Irino, Y., Sato, N., Takeuchi, Y., Kyotani, K., Mukasa, A., Mizukawa, K., Sakata, J., Yamamoto, Y., Hosoda, K., Itoh, T., Sasaki, R., & Kohmura, E. (2016). Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy forIDH1mutant glioma. Neuro-Oncology, now090. https://doi.org/10.1093/neuonc/now090 [doi]

Cite this abstract